
Galileo Trochanteric Nail System ↗
Trochanteric and ES nails with lag screw options for proximal femoral fracture fixation. [16]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Orthopedic trauma implants, intramedullary nails, fracture plates, screws and external fixation systems.
Advanced Orthopaedic Solutions (AOS) designs, manufactures and markets orthopedic trauma implants and instruments. Founded in 2001 and headquartered in Torrance, California, it specializes in intramedullary fixation and related systems for fracture care.
The portfolio spans Galileo trochanteric nails, Magellan femoral nails, Da Vinci tibial nails, Newton humeral nails and fibular nails, together with Fibonacci lower-extremity plates, proximal humeral and clavicle systems, external fixation and cannulated screws. Its systems support upper- and lower-extremity trauma procedures.
The company’s published management page identifies Gary Sohngen as founder and president and Michael Payne as founder and vice president of sales and marketing. Omni Orthopedics names AOS among its represented manufacturers on its president’s professional profile; product-specific rights and manufacturer confirmation have not been established.
The reviewed FDA applicant records contain 28 distinct 510(k) decisions. Twenty-seven are mapped at family level to the displayed commercial portfolio; K141228 for a 6.5 mm captured cancellous screw remains outside the current totals because its relationship to the current 7.0 mm offering was not established. Shared manufacturing and component decisions are counted once. No matching De Novo grants or original PMA approvals were identified in the reviewed applicant and product searches. [31][43][34]
FDA records document one historical Class II recall event (54538), represented by 12 recall numbers for specified legacy AOS Trochanteric Nails. It was initiated January 14, 2010 after an incorrectly bent nail was found, and is listed as terminated. These affected legacy models have not been matched to the current marketed Galileo configurations and are excluded from the current-portfolio recall total. No open AOS recall event was identified in the reviewed firm-name and FEI searches. [17][35][58][59][60][61][62][63][64][65][66][67]
Latest recorded source review: 2026-10-22.
Documented commercial product families.

Trochanteric and ES nails with lag screw options for proximal femoral fracture fixation. [16]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Antegrade and retrograde intramedullary nails for femoral fractures. [18]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Intramedullary tibial fixation with instrumentation for standard and suprapatellar approaches. [19]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Humeral intramedullary nails and targeting instruments for fracture fixation. [20]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Small-bone intramedullary nails for the fibula, with manufacturer-described radius and ulna applications. [21]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Lower-extremity plates and screw options, including ankle and proximal tibial applications. [22]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Anatomic locking plates and screws for proximal humeral fracture fixation. [23]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Clavicle plates, screws and an intramedullary fixation option. [24]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Rods, pins and clamps for temporary stabilization of fractures and spanning joints. [25]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

External fixation components for smaller bones and extremity reconstruction. [26]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

Cannulated bone screws and associated fracture-fixation instrumentation. [27]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.

A modular femoral nail using interchangeable inserts for antegrade, retrograde, reconstruction and other configurations. [28]
FDA-clearedListed in the manufacturer’s current U.S. portfolio.
Publicly documented relationships; coverage may be incomplete.
| Partner | Territory / scope | Products |
|---|---|---|
| Omni Orthopedics, Inc. (distributor-reported) [70] | Ohio and Kentucky (reported service area; manufacturer-specific territory unconfirmed) | AOS portfolio representation; specific products not established |
Sources checked October 22, 2026.
Accessed 10/28/2026
Last substantive review: 10/22/2026